ADMA BIOLOGICS, INC. (ADMA) Capital expenditures 2016–2025
ADMA BIOLOGICS, INC. (ADMA) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$22.6MFY2025 · since FY2016: $73,410 → $22.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $22.6M | +174.4% |
| FY2024 | $8.2M | +72.4% |
| FY2023 | $4.8M | -65.7% |
| FY2022 | $13.9M | +3.0% |
| FY2021 | $13.5M | +6.2% |
| FY2020 | $12.7M | +233.9% |
| FY2019 | $3.8M | +81.9% |
| FY2018 | $2.1M | -21.7% |
| FY2017 | $2.7M | +3545.7% |
| FY2016 | $73,410 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice